Timothy Kelly
Net worth: 172 575 $ as of 2026-05-30
Net worth: 172 575 $ as of 2026-05-30
Timothy P.
Kelly currently works at Caribou Biosciences, Inc., as Chief Technology Officer from 2024.
Mr. Kelly also formerly worked at Oxford Biomedica Solutions LLC, as Chairman & Chief Executive Officer from 2022 to 2023, Biogen, Inc., as Senior Director-International Operations from 1998 to 2005, Sarepta Therapeutics, Inc., as Head-Technical Operations in 2017, Shire Plc, as Senior Vice President & Head-Biologics Operating from 2016 to 2017, UCB SA, as Head-Technical Operations from 2005 to 2009, and Homology Medicines, Inc., as Chief Operating Officer from 2021 to 2022.
Mr. Kelly received his undergraduate degree from United States Air Force Academy and Masters Business Admin degree from Troy University.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-02-24 | 73,125 ( 0.07% ) | 172 575 $ | 2026-05-30 |
| Companies | Position | Start |
|---|---|---|
| CARIBOU BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | 2024-01-06 |
| Companies | Position | End |
|---|---|---|
Oxford Biomedica Solutions LLC
Oxford Biomedica Solutions LLC Industrial MachineryProducer Manufacturing Operates as an AAV focused manufacturing and innovation company | Chief Executive Officer | 2023-06-30 |
| Q32 BIO INC. | Chief Operating Officer | 2022-03-09 |
| SAREPTA THERAPEUTICS, INC. | Corporate Officer/Principal | 2017-04-30 |
| SHIRE | Corporate Officer/Principal | 2016-12-31 |
| UCB | Corporate Officer/Principal | 2008-12-31 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 9 |
|---|---|
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Sarepta Therapeutics, Inc.
Sarepta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures micro-dystrophin gene therapy | Health Technology |
Shire Plc
Shire Plc Pharmaceuticals: MajorHealth Technology Develops and markets medicines for patients with rare diseases | Health Technology |
Caribou Biosciences, Inc.
Caribou Biosciences, Inc. BiotechnologyHealth Technology Develops technology-based solutions for cellular engineering and analysis | Health Technology |
UCB SA
UCB SA Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
United States Air Force Academy
United States Air Force Academy Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Troy University
Troy University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Homology Medicines, Inc.
Homology Medicines, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage genetic medicines company | Health Technology |
Oxford Biomedica Solutions LLC
Oxford Biomedica Solutions LLC Industrial MachineryProducer Manufacturing Operates as an AAV focused manufacturing and innovation company | Producer Manufacturing |
Select your edition
All financial news and data tailored to specific country editions